MoonLake Immunotherapeutics
MLTX
Jodie situation report
MoonLake Immunotherapeutics's current read is isolated; its market group is not confirming.
No new filing conclusion is available. 0 of 27 group members are active now; 0 filing-linked outsiders are moving with the group, and 0 of 3 directly disclosed connections are confirming.
- MLTX's market-adjusted activity becomes unusual and at least one connected name confirms.
Invalidation: The isolated read changes if MLTX's group or a disclosed connection begins moving with it.
Who this business touches
The relationships behind MLTX
Customers, suppliers, partners and competitors named in company filings—not inferred from headlines.
Depends on
MRKMerck & Company, Inc.partnerFeb 25, 2026 ▾
“We are currently a single asset company focused on the development of Sonelokimab ( “ SLK ”) , a novel tri-specific IL-17A and IL-17F inhibiting Nanobody, that we exclusively licensed from Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA,…”
HTGCHercules Capital, Inc.lenderMay 11, 2026 ▾
“Term Loan Facility In March 2025, we entered into a loan and security agreement (the “Original Loan and Security Agreement”) with Hercules Capital, Inc.”
Depended on by
ORKAOruka Therapeutics, Inc.partnerMar 12, 2026 ▾
“These include the biologic sonelokimab from MoonLake Immunotherapeutics targeting IL-17A/F, and several oral agents in development, including JNJ-2113 (icotrokinra) from Janssen targeting the IL-23 receptor, DC-853 (simepdekinra) from Eli Lilly targeting IL-1…”
Filing peers
Companies whose filings use similar operating language.
Open the three relationships above to see Jodie’s filing proof. Pro unlocks 3 more links, every receipt, and alerts when connected names begin moving. Unlock the full network →
What is moving around it
Live connections
MLTX is currently a Follower in the organic co-movement group Semiconductor Equipment & Services. This group is discovered from market behaviour rather than assigned from an industry taxonomy. 3 filing-linked names are in the relationship map; none is currently confirmed as moving with the group.
This group is retained as the last observed read for MLTX; it is not active in the latest market snapshot.